Association between second-generation antipsychotics and newly diagnosed treated diabetes mellitus: does the effect differ by dose?

Off-Label Use of Antipsychotic Medications in the Department of Veterans Affairs Health Care System

(2014) Douglas L. Leslie et al.   PSYCHIATRIC SERVICES

A real-world data analysis of dose effect of second-generation antipsychotic therapy on hemoglobin A1C level

(2011) Zhenchao Guo et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Treatment with antipsychotics and the risk of diabetes in clinical practice

(2010) Lars Vedel Kessing et al.   BRITISH JOURNAL OF PSYCHIATRY

Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naïve Schizophrenia Patients

(2010) Jimmi Nielsen et al.   NEUROPSYCHOPHARMACOLOGY

The incidence of diabetes in atypical antipsychotic users differs according to agent-results from a multisite epidemiologic study

(2009) Marianne Ulcickas Yood et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Dose trends for second-generation antipsychotic treatment of schizophrenia and bipolar disorder

(2008) Leslie Citrome et al.   SCHIZOPHRENIA RESEARCH